|
B4GALT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.180200E-03 |
| Normal-vs-Stage3 |
8.17110000000953E-05 |
| Normal-vs-Stage4 |
4.953700E-04 |
| Stage1-vs-Stage2 |
5.321400E-01 |
| Stage1-vs-Stage3 |
3.381400E-01 |
| Stage1-vs-Stage4 |
5.178000E-04 |
| Stage2-vs-Stage3 |
8.988800E-01 |
| Stage2-vs-Stage4 |
3.430400E-02 |
| Stage3-vs-Stage4 |
6.135800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
4.0383999477811E-09 |
| Normal-vs-Asian |
1.833390E-01 |
| Caucasian-vs-AfricanAmerican |
1.474240E-02 |
| Caucasian-vs-Asian |
2.354600E-01 |
| AfricanAmerican-vs-Asian |
5.057800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.64570024274724E-10 |
| Male-vs-Female |
6.471400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.02909999999346E-05 |
| Normal-vs-Extreme_Weight |
2.90678592307358E-12 |
| Normal-vs-Obese |
1.60860003095564E-09 |
| Normal-vs-Extreme_Obese |
1.529860E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.698400E-01 |
| Normal_Weight-vs-Obese |
1.875600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.066000E-01 |
| Extreme_Weight-vs-Obese |
3.633400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.050200E-01 |
| Obese-vs-Extreme_Obese |
9.033600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.822610E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6251444634463E-12 |
| Normal-vs-Age(81-100Yrs) |
1.142580E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.573200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.607600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.067400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.407400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.236760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.204800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
6.5404004434555E-10 |
| Normal-VS-KIRP CIMP |
1.150220E-01 |
| Normal-VS-Unclassified PRCC |
3.89840000003527E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.894000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.100440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.086600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.756200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.644810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.158550E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.91310000000156E-06 |
| Normal-vs-N1 |
1.776170E-04 |
| Normal-vs-N2 |
1.956990E-01 |
| N0-vs-N1 |
7.027600E-01 |
| N0-vs-N2 |
6.202000E-01 |
| N1-vs-N2 |
4.647400E-01 |
|
|
